Biotech

The chief executive of Amgen Inc (AMGN.O) forecast on Monday that "smart" biotechnology companies may be able to retain up to half the sales of their drugs once they face competition from cheaper so-called biosimilars. Kevin Sharer, speaking to investors at Deutsche Bank AG's annual healthcare...

SO far, San Diego remains a fertile breeding ground for entrepreneurs, despite the problems in the broader economy. Connect, a nonprofit organization led by Duane Roth, right, helped husband and wife Rolf Muller and Judy Muller-Cohn obtain a $1 million investment to start Biomatrica, their business That...

It's that time of year again, the annual celebration of the progress of the biotech industry around the globe. This year's fiesta, known as the BIO International Conference, will go to a new venue for the first time: Atlanta, Georgia. But don't fret too...

There are no plans to hang crepe inside the Georgia World Congress Center, but the 2009 BIO International Convention will take place here this week against the backdrop of the toughest economic times ever witnessed by this still-young industry. Venture capital investments in biotech companies have...

Almost unnoticed amid the revival of stem cell politics this year, progress and peril in the science behind the controversy continues to hum along. Human embryonic stem cells, with their ability to turn into every kind of organ tissue in the body, have tantalized biomedical researchers...

University of Wisconsin-Madison cancer researcher Jing Zhang received a Shaw Scientist Award last week from the Greater Milwaukee Foundation to support her novel research on the roles cancer stem cells may play in the causes and treatment of cancer. The Shaw Award - a $200,000 unrestricted...

In 2003, when Foundation Capital, a venture capital firm, started looking for new investors for Silver Spring Networks, one of its portfolio of companies, it was rejected by every firm it called. Silver Spring Networks puts network cards in electric meters to more closely track power...

There's no question that biology is a booming business, even in these down times. During the past 25 years, big advances in the biological sciences have revolutionized health care and agriculture, set a foundation for new kinds of industries, manifest in the clusters of biotech companies...

Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of...